-------------------------------------------------------------------------
Unlimited authorization of preferred shares,
non-participating, non-voting without par
value; none outstanding - -
-------------------------------------------------------------------------
Warrants 541 541
-------------------------------------------------------------------------
Contributed surplus 13,410 12,527
-------------------------------------------------------------------------
Deficit (214,616) (205,024)
-------------------------------------------------------------------------
Accumulated other comprehensive income (loss) 19 (50)
-------------------------------------------------------------------------
Total shareholders' equity 41,312 49,949
-------------------------------------------------------------------------
91,323 99,539
-------------------------------------------------------------------------
-------------------------------------------------------------------------
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
-------------------------------------------------------------------------
For the three months ended: March 31, March 31,
2008 2007
-------------------------------------------------------------------------
(Thousands of Canadian dollars, except share
and per share amounts) $ $
--------------------
'/>"/>
| SOURCE Labopharm Inc. Copyright©2008 PR Newswire. All rights reserved |